Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Director/PDMR Shareholding

29 Jul 2024 14:36

RNS Number : 2549Y
Indivior PLC
29 July 2024
 

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM

The Company announces that it received notification on July 26, 2024 that Vishal Kalia, aPDMR and Company's Chief Strategy and Global Impact Officer, purchased 4,664 Ordinary Shares of US$0.50 each in the Company ('Shares') at a price of US$12.71 per share on July 26, 2024.

Following this transaction, Vishal Kalia has an interest in 129,611 Shares.

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Vishal Kalia

 

2

 

Reason for the notification

 

 

a)

 

Position/status

  

PDMR - Chief Strategy and Global Impact Officer

 

b)

 

Initial notification /Amendment 

 

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

 

Name

Indivior PLC

 

b)

 

LEI

213800V3NCQTY7IED471

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

 

GB00BN4HT335

 

 

b)

 

Nature of the transaction

Purchase of Shares

 

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

US$12.71

4,664

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

July 26, 2024

f)

 

Place of the transaction

 

Nasdaq Global Select Market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPUAWMUPCGWB
Date   Source Headline
27th Jun 20222:55 pmRNSRetraction - Holdings in Company
24th Jun 202211:45 amRNSSettlement with Dr. Reddy’s Laboratories
24th Jun 202211:40 amRNSHolding(s) in Company
24th Jun 20227:00 amRNSTransaction in Own Shares
23rd Jun 20227:00 amRNSTransaction in Own Shares
22nd Jun 20222:00 pmRNSHolding(s) in Company
22nd Jun 20227:00 amRNSTransaction in Own Shares
21st Jun 20221:15 pmRNSHolding(s) in Company
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20221:18 pmRNSHolding(s) in Company
20th Jun 20227:00 amRNSTransaction in Own Shares
17th Jun 20227:00 amRNSTransaction in Own Shares
16th Jun 20227:00 amRNSTransaction in Own Shares
15th Jun 20227:00 amRNSTransaction in Own Shares
14th Jun 20227:00 amRNSTransaction in Own Shares
13th Jun 20227:00 amRNSTransaction in Own Shares
10th Jun 20227:00 amRNSTransaction in Own Shares
9th Jun 20227:00 amRNSTransaction in Own Shares
8th Jun 20227:00 amRNSTransaction in Own Shares
7th Jun 20227:00 amRNSTransaction in Own Shares
6th Jun 20227:00 amRNSTransaction in Own Shares
1st Jun 202212:53 pmRNSFirst patient enrolled in AEF0117 Phase 2b study
1st Jun 20227:30 amRNSTotal Voting Rights
1st Jun 20227:00 amRNSTransaction in Own Shares
31st May 20227:00 amRNSTransaction in Own Shares
30th May 20227:00 amRNSTransaction in Own Shares
27th May 20227:00 amRNSTransaction in Own Shares
26th May 20227:00 amRNSTransaction in Own Shares
25th May 20227:00 amRNSTransaction in Own Shares
24th May 20229:00 amRNSIndivior to Participate in Conference
24th May 20227:00 amRNSTransaction in Own Shares
23rd May 202210:22 amRNSHolding(s) in Company
23rd May 20227:00 amRNSTransaction in Own Shares
20th May 20227:00 amRNSTransaction in Own Shares
19th May 20227:00 amRNSTransaction in Own Shares
18th May 202210:08 amRNSDirector Declaration
18th May 20227:00 amRNSTransaction in Own Shares
17th May 202212:32 pmRNSHolding(s) in Company
17th May 20227:00 amRNSTransaction in Own Shares
16th May 20227:00 amRNSTransaction in Own Shares
13th May 20227:00 amRNSTransaction in Own Shares
12th May 20227:00 amRNSTransaction in Own Shares
11th May 20227:00 amRNSTransaction in Own Shares
10th May 202210:59 amRNSBlock listing Interim Review
10th May 20227:00 amRNSTransaction in Own Shares
9th May 20227:00 amRNSTransaction in Own Shares
6th May 20227:00 amRNSTransaction in Own Shares
5th May 20222:55 pmRNSResult of AGM
5th May 20227:00 amRNSTransaction in Own Shares
4th May 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.